Subscribe to our latest updates, reports and upcoming events. Subscribe >
De Para
Subscribe to our latest updates, reports and events.
SubscribeShowing 1 - 10 of 109
Ordenar por
Article 7 abr 2021
The accessibility of medicinal cannabis took another step forward on 22 March when Scotland’s first medicinal cannabis clinic was given authority to open by the regulator. Against this background, we consider the state of play of medicinal cannabis in the UK since its legalisation in 2018 and explore some potential product liability implications that may arise.
Report 30 mar 2021
The vulnerabilities of the life science supply chain are at the forefront of everyone’s minds, but, behind the headlines, how is the pandemic affecting attitudes to risk?
Article 30 mar 2021
On 26 March 2021, the Victorian Court of Appeal handed down its highly anticipated judgment in the construction consultants’ appeal of the 2019 Lacrosse decision.
Article 30 mar 2021
The facts of the Lacrosse case are well known. In November 2014, a late night cigarette discarded on a balcony of the 21-storey Lacrosse building in Docklands, Victoria, ignited a fire that spread to the external cladding, resulting in excess of A$12 million in damage.
Article 29 mar 2021
This country-specific Q&A provides an overview of product liability laws and regulations applicable in United Kingdom.
Article 26 mar 2021
On March 25, 2021, the Supreme Court issued its opinion in Ford Motor Company v. Montana Eighth Judicial District Court, et al., expanding the criteria for the exercise of personal jurisdiction over defendants that transact business in multiple states.
Article 22 mar 2021
For some time, the regulatory framework applicable to cannabis products in Europe has been widely recognised as being particularly complex. As a result of this, companies frequently struggle with successfully navigating the regulatory regimes applicable in each country in which they sell. This looks set to continue as new UK requirements come into force on 1 April 2021.
Article 19 mar 2021
We have advised that minimum safety standard for an autonomous vehicle (AV) should be above that of the “average” human driver as to do anything less than this is to risk public confidence in this emergent technology.
Article 4 mar 2021
2020 was a challenging year globally. However, the start of 2021 has welcomed the rapid roll out of the breakthrough COVID-19 vaccines in the UK, a ray of hope for a way out of the pandemic. Over 20 million people in the UK have already been given vaccine doses, with the hope that the majority of the UK adult population will be vaccinated by the end of 2021.
Article 19 fev 2021
The outcome of two Canadian product class actions in 2020 signal hurdles claimants may face around the globe in 2021 in alleging adverse health effects in mass tort claims involving products for consumption such as medical cannabis, other pharmaceutical products and food.
